• SELECT SITE CURRENCY
Select a currency for use throughout the site
Global Cardiac Markers Device Market 2010-2014
Infiniti Research Limited, November 2011, Pages: 28
TechNavio’s analysts forecast the Global Cardiac Markers Device market to grow at a CAGR of 5.7 percent over the period 2010–2014. One of the key factors contributing to this market growth is the rise in cardiovascular diseases. The Global Cardiac Markers market has also been witnessing the adoption of personalized medical services by healthcare organizations. However, the lack of medical reimbursement for cardiac markers could pose a challenge to the growth of this market. TechNavio’s report Global Cardiac Markers Device Market 2010–2014, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions. It analyzes the current Global Cardiac Markers market landscape and its growth prospects. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market include Hoffman-La Roche, Abbott Laboratories, Siemens Healthcare, and Alere Inc.
Key questions answered in this report:
What will the market size be in 2014 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
01. Executive Summary
03. Market Coverage
04. Market Landscape
05. Vendor Landscape
06. Buying Criteria
07. Market Growth Drivers
08. Drivers and their Impact
09. Market Challenges
10. Market Trends
11. Key Vendor Analysis
11.1 Hoffman La Roche
11.2 Abbott Laboratories
11.3 Siemens Healthcare
11.4 Alere Inc.
12. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Cardiac Markers Device Market 2010–2014 (US$ millions)
Exhibit 2: Global Cardiac Markers Device market by Product Segmentation–2010
Exhibit 3: Global Cardiac Markers Device Market by Geographical Segmentation –2010
Exhibit 4: Global Cardiac Markers by Vendor Segmentation–2010
TechNavio Announces the Publication of its Report – Global Cardiac Markers Device Market 2010–2014
TechNavio today launched its report, Global Cardiac Markers Device Market 2010–2014, which is based on an in-depth study of the Americas and the EMEA and APAC regions. The report aims to aid decision makers understand the key trends driving the growth of this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said, “The Global Cardiac Markers Device market has witnessed a spate of M&A by leading vendors. These M&A are being undertaken to increase vendors' global presence, mitigate loss of patent protection, and achieve economies of scale. This has enabled substantial synergies for companies, including an enviable combination of a global customer base and a complementary high-growth portfolio of products and solutions.”
According to the report, there has been a steep rise in the number of patients affected by cardiovascular diseases owing to changes in lifestyle. Cardiovascular diseases are the leading cause of mortality in Western countries, accounting for over 40 percent of the total deaths each year. Thus, the demand for cardiac markers is increasing because they can help in early diagnosis and treatment. The report also discusses the voluntary recalls of cardiac markers which have been hindering the growth of this market.
The study was carried out using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
Hoffman-La Roche, Abbott Laboratories, Siemens Healthcare and Alere Inc
A sample for this product is available. Please Login/Register to download this sample.